Table 2 The characteristics of study population in the Study on global AGEing and adult health from China
From: Associations between sarcopenia with asthmatic prevalence, lung function and comorbidity
No sarcopenia | Non-severe sarcopenia | Severe sarcopenia | P | |
|---|---|---|---|---|
N | 8998 | 753 | 512 | |
Age | 68.8 ± 6.9 | 73.0 ± 7.2 | 76.1 ± 7.3 | < 0.01 |
Sex | < 0.01 | |||
Male | 4506 (50.1%) | 312 (41.4%) | 199 (38.9%) | |
Female | 4492 (49.9%) | 441 (58.6%) | 313 (61.1%) | |
Region | 0.01 | |||
North | 2754 (30.6%) | 195 (25.9%) | 141 (27.5%) | |
South | 6244 (69.4%) | 558 (74.1%) | 371 (72.5%) | |
Urban/Rural | < 0.01 | |||
Urban | 4985 (55.4%) | 297 (39.4%) | 151 (29.5%) | |
Rural | 4013 (44.6%) | 456 (60.6%) | 361 (70.5%) | |
Married status | < 0.01 | |||
Current unmarried | 1790 (19.9%) | 253 (33.6%) | 205 (40.0%) | |
Current married | 7208 (80.1%) | 500 (66.4%) | 307 (60.0%) | |
Alochol | 0.05 | |||
Ever | 2349 (26.1%) | 175 (23.2%) | 115 (22.5%) | |
Never | 6649 (73.9%) | 578 (76.8%) | 397 (77.5%) | |
Smoking | 0.73 | |||
Never | 6302 (70.0%) | 522 (69.3%) | 371 (72.5%) | |
Ever | 888 (9.9%) | 72 (9.6%) | 44 (8.6%) | |
Current | 1808 (20.1%) | 159 (21.1%) | 97 (18.9%) | |
Body mass index | < 0.01 | |||
Underweight | 131 (1.5%) | 231 (30.7%) | 146 (28.5%) | |
Normal | 3992 (44.4%) | 521 (69.2%) | 364 (71.1%) | |
Overweight | 3525 (39.2%) | 1 (0.1%) | 2 (0.4%) | |
Obesity | 1350 (15.0%) | 0 (0.0%) | 0 (0.0%) | |
Moderate-intensity activity | < 0.01 | |||
Yes | 2840 (31.6%) | 304 (40.4%) | 188 (36.7%) | |
No | 6158 (68.4%) | 449 (59.6%) | 324 (63.3%) | |
Vigorous-intensity activity | 0.61 | |||
Yes | 748 (8.3%) | 66 (8.8%) | 37 (7.2%) | |
No | 8250 (91.7%) | 687 (91.2%) | 475 (92.8%) | |
Night sleep duration | < 0.01 | |||
< 360 min | 751 (8.3%) | 79 (10.5%) | 62 (12.1%) | |
360–419 min | 1210 (13.4%) | 92 (12.2%) | 53 (10.4%) | |
420-479 min | 1958 (21.8%) | 126 (16.7%) | 58 (11.3%) | |
480-539 min | 2890 (32.1%) | 224 (29.7%) | 122 (23.8%) | |
≥ 540 min | 2189 (24.3%) | 232 (30.8%) | 217 (42.4%) | |
Hypertension | < 0.01 | |||
No | 5359 (59.6%) | 586 (77.8%) | 403 (78.7%) | |
Yes | 3639 (40.4%) | 167 (22.2%) | 109 (21.3%) | |
Diabetes | < 0.01 | |||
No | 8082 (89.8%) | 718 (95.4%) | 489 (95.5%) | |
Yes | 916 (10.2%) | 35 (4.6%) | 23 (4.5%) | |
Stroke | 0.22 | |||
No | 8051 (89.5%) | 685 (91.0%) | 467 (91.2%) | |
Yes | 947 (10.5%) | 68 (9.0%) | 45 (8.8%) | |
Angina | 0.32 | |||
No | 8486 (94.3%) | 720 (95.6%) | 483 (94.3%) | |
Yes | 512 (5.7%) | 33 (4.4%) | 29 (5.7%) | |
Chronic lung diseases | < 0.01 | |||
No | 8101 (90.0%) | 654 (86.9%) | 434 (84.8%) | |
Yes | 897 (10.0%) | 99 (13.1%) | 78 (15.2%) | |
Arthritis | 0.01 | |||
No | 6879 (76.5%) | 615 (81.7%) | 376 (73.4%) | |
Yes | 2119 (23.5%) | 138 (18.3%) | 136 (26.6%) | |
Asthma | 0.1 | |||
No | 8733 (97.1%) | 724 (96.1%) | 490 (95.7%) | |
Yes | 265 (2.9%) | 29 (3.9%) | 22 (4.3%) | |
FEV1 | 1.7 ± 0.7 | 1.5 ± 0.7 | 1.3 ± 0.7 | < 0.01 |
FEV1/FVC | < 0.01 | |||
≥ 0.7 | 7252 (80.6%) | 555 (73.7%) | 352 (68.8%) | |
< 0.7 | 1746 (19.4%) | 198 (26.3%) | 160 (31.2%) | |
PEF | 78.6 ± 19.9 | 76.6 ± 19.5 | 73.8 ± 21.0 | < 0.01 |
FEF25-75 | 2.0 ± 1.1 | 1.6 ± 1.1 | 1.3 ± 1.0 | < 0.01 |